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ABSTRACT
A hallmark of metazoan RNA polymerase II tran-
scripts is the presence of numerous small exons
surrounded by large introns. Abundant evidence in-
dicates that splicing to excise introns occurs
co-transcriptionally, prior to release of the nascent
transcript from RNAP II. Here, we established an
efficient model system for co-transcriptional
splicing in vitro. In this system, CMV-DNA con-
structs immobilized on beads generate RNAP II
transcripts containing two exons and an intron.
Consistent with previous work, our data indicate
that elongating nascent transcripts are tethered to
RNAP II on the immobilized DNA template. We show
that nascent transcripts that reach full length, but
are still attached to RNAP II, are efficiently spliced.
When the nascent transcript is cleaved within the
intron using RNase H, both the 50 and 30 cleavage
fragments are detected in the bound fraction,
where they undergo splicing. Together, our work
establishes a system for co-transcriptional splicing
in vitro, in which the spliceosome containing the
50 and 30 exons are tethered to RNAP II for splicing.
INTRODUCTION
In higher eukaryotes, RNAP II transcripts are typically
thousands of nucleotides in length, containing numerous
small exons separated by large introns (1–6). A long-
standing problem in the splicing ﬁeld has been to under-
stand the mechanisms for ensuring that each upstream
exon is ligated only to the adjacent downstream exon,
without skipping any of the exons. Superimposed upon
this problem, >95% of multi-exon transcripts undergo
alternative splicing, in which different combinations of
exons are used to generate a wide diversity of protein
isoforms (5,6). A large body of work in vivo indicates
that splicing occurs co-transcriptionally, prior to release
of the nascent transcript from RNAP II [for reviews, see
(2,7–10)]. Indeed, recent qPCR data showed that most
constitutive exons are removed co-transcriptionally and
that alternative exon choice also occurs during transcrip-
tion (11). In addition, both in vivo and in vitro studies
indicate that splicing is functionally coupled to RNAP II
transcription (2,7–9). These results have raised the possi-
bility that RNAP II plays a key role in correct pairing of
adjacent exons in multi-exon transcripts. In one model,
the nascent upstream exon is tethered to RNAP II until
the adjacent downstream exon is synthesized. The two
tethered exons are associated with one another via inter-
actions within the spliceosome (12). In previous work
in vivo, Dye and co-workers (13) obtained support for
the RNAP II exon-tethering model by showing that a
nascent RNAP II transcript that is co-transcriptionally
cleaved within the intron is spliced as efﬁciently as the
nascent transcript containing an intact intron. These
data indicate that the 50 and 30 exons are tethered to one
another via RNAP II (13).
Recently, in vitro systems for coupling transcription to
splicing have been developed (14–18). In the coupled
reaction, the nascent transcript is rapidly and quantitative-
ly packaged into the spliceosome, which stabilizes the
transcript and results in efﬁcient splicing (14–17).
However, at present, an efﬁcient model in vitro system
for co-transcriptional splicing, in which splicing occurs
while the nascent transcript is still associated with
RNAP II, remains to be established. Here, we combined
our coupled transcription/splicing system with a
well-established immobilized template assay in which
emerging nascent transcripts remain attached to RNAP
II bound on the immobilized DNA template [(19–26)
and references therein]. Using this approach, we show
that bound, full-length nascent transcripts undergo efﬁ-
cient splicing. Moreover, when RNase H is used to
cleave the transcript within the intron, both the 50 and
30 portions of the transcript are detected in the bound
fraction. We provide evidence that these 50 and
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CMV-DoF1 plasmid was described previously (15).
CMV-ATM (27) was a generous gift from M. Passoni
(Trieste, Italy). RNAP II transcription templates were
generated by PCR from each plasmid using a biotinylated
50 primer (50-biotin-TGG AGG TCG CTG AGT AGT
GC-30) or a biotinylated 30 primer (50-TAG AAG GCA
CAG TCG AGG-biotin-30). The biotin was linked to the
oligonucleotide via a 15-atom spacer (TEG, Operon). The
same oligonucleotides without biotin were used to
generate non-biotinylated PCR products where indicated.
The resulting PCR products were puriﬁed using phenol
extraction followed ethanol precipitation and used as
RNAP II transcription templates.
RNAP II transcription/splicing using immobilized
CMV-DNA template
For in vitro RNAP II transcription/splicing reactions,
200ng biotinylated CMV-DNA templates were bound to
10ml of streptavidin magnetic particles (Roche) for 30min
and washed according to the manufacturer’s protocol. The
beads were incubated under RNAP II transcription/
splicing conditions at 30 C for the indicated times in
25ml reaction mixtures containing 1ml
32P-UTP or CTP
(800Ci/mmol), 0.5mM ATP, 3.2mM MgCl2 and 20mM
creatine phosphate (di–Tris salt) and 15ml HeLa nuclear
extract (28) (note that for nuclear extract preparation, the
ﬁnal centrifugation following dialysis is omitted, which
results in more active extracts). Addition of extra NTPs
does not affect the efﬁciency of transcription/splicing in
these extracts, possibly because sufﬁcient NTPs remain in
the extract bound to proteins in an exchangeable manner.
Actinomycin D (250ng/25ml reaction) was used to block
transcription after 3, 5 or 10min followed by continued
incubation for times indicated in each ﬁgure. For PIC for-
mation with PVA, the immobilized DNA template was
incubated with 3.2mM MgCl2,2ml PVA and 15ml HeLa
nuclear extract at 30 C for 20min, and then 20mM
creatine phosphate (di–Tris salt), 0.5mM ATP and 1ml
32P-CTP (800Ci/mmol) were added to initiate transcrip-
tion and splicing. Bound and supernatant fractions were
separated using a magnetic separator, and bound fractions
were washed gently three times with 500ml of immobilized
wash buffer (20mM HEPES pH 7.6, 20% glycerol,
0.2mM EDTA, 0.1% Triton X-100 and 100mM KCl).
For RNase H cleavage, immobilized CMV-ATM was
incubated under RNAP II transcription/splicing condi-
tions for 3 or 5min as indicated, followed by addition of
actinomycin D and a 12-mer oligonucleotide (50-AAGCT
TCACCCG-30) complementary to transcript. Incubation
was continued at 30 C for indicated times. After incuba-
tion, bound and supernatant fractions were separated,
and bound fractions were washed gently three times
with 500ml of immobilized wash buffer containing
100mM KCl. Total RNA was precipitated and analyzed
on denaturing polyacrylamide gels. Bands were detected
by phosphoimager.
RESULTS
To develop a model in vitro system for co-transcriptional
splicing, we took advantage of an extensive body of work
in the transcription ﬁeld showing that ternary complexes
containing the DNA template, RNAP II, and the nascent
transcript assemble in nuclear extracts on DNA templates
immobilized on a bead (18–26,29–32). For our work, we
used a system in which the DNA template was attached to
a magnetic streptavidin bead via a biotin moiety
(24,25,30,31). To do this, a  1.6kb DNA template con-
taining the CMV promoter and encoding the Ftz splicing
substrate was ampliﬁed by PCR using primers containing
either an upstream (50b) or downstream (30b) biotinylated
nucleotide (Figure 1A). The same DNA template contain-
ing no biotin was used as a negative control (–b)
(Figure 1A). Analysis of the PCR products by ethidium
bromide staining (Figure 1B, lanes 1–3) or uniform
labeling (Figure 1B, lanes 4–6) showed that one speciﬁc
PCR product of the correct size was generated, and the
levels of this product were similar for 50b, 30b and –b DNA
templates. When these PCR products were mixed with
streptavidin magnetic beads, the biotinylated, but not
the non-biotinylated, DNA templates speciﬁcally bound
to the beads (Figure 1C, lanes 1–9). Moreover, when the
immobilized 50b, 30b and –b CMV-Ftz DNA templates
were incubated in nuclear extract for 30min under our
standard RNAP II transcription/splicing conditions (15),
the biotinylated DNA templates did not detach, as they
were detected only in the bound and not in the super-
natant fractions (Figure 1D, lanes 1–4). As expected, the
–b DNA template was not detected in either fraction
(lanes 5 and 6). Together, these data indicated that the
50b and 30b CMV-Ftz DNA templates were present in
similar amounts, bound speciﬁcally to the streptavidin
beads, and remained quantitatively bound to the beads
under RNAP II transcription/splicing conditions.
To further characterize the biotinylated DNA tem-
plates, we carried out an RNAP II transcription/splicing
reaction using the 50b, 30b or -b CMV-Ftz DNA templates
free in solution. As shown in Figure 1E, bands of the
expected sizes for the unspliced transcript (775nt) and
spliced transcript (608nt) were detected with all of the
templates, indicating that both RNAP II transcription
(lanes 1, 3 and 5) and splicing (lanes 2, 4 and 6)
occurred with similar efﬁciency with these templates
[Note that U6 snRNA in the nuclear extract was labeled
by the
32P-UTP in the reaction mixture, as observed in
previous work (33)]. We then carried out the same
RNAP II transcription/splicing reaction using the
immobilized DNA templates (Figure 1F). Importantly,
these data revealed that both RNAP II transcription and
splicing occur as efﬁciently using the immobilized DNA
templates as with the DNA templates free in solution,
indicating that the presence of the bead did not interfere





Figure 1. Efﬁcient RNAP II transcription and splicing on immobilized CMV-Ftz DNA templates. (A) Schematic of CMV-Ftz DNA templates are
shown, indicating the position of the biotin. The sizes of the CMV promoter and Ftz exons and intron are indicated. The gray circle represents the
streptavidin magnetic bead. (B) CMV-Ftz DNA templates containing biotin at the 50 (50b) or 30 end (30b), or no biotin (-b) were constructed by PCR
and detected on an ethidium bromide gel (lanes 1–3) or by uniform labeling (lanes 4–6). (C) Immobilized 50b, 30b and –b CMV-Ftz DNA templates
were mixed with streptavidin magnetic beads, and after washing, bound (bnd) and supernatant (sup) fractions were analyzed on a 1% agarose gel
stained with ethidium bromide. Total input is shown (lanes 1, 4 and 7). (D) Biotinylated CMV-Ftz DNA templates were uniformly labeled, bound to
streptavidin magnetic beads, followed by incubation in nuclear extract at 30  for 30min. Bound (1, 3 and 5) and supernatant (2, 4 and 6) fractions
were analyzed on a 6.5% denaturing polyacrylamide gel. The arrow in panels B, C and D indicate the Ftz DNA template. Marker in panels B and C
are in kilobases. (E and F) Free (E) or immobilized (F) CMV-Ftz DNA templates were incubated under RNAP II transcription/splicing conditions
for 5min, actinomycin D was added, and incubation was continued for another 25min. Total RNA was fractionated on a 6.5% denaturing
polyacrylamide gel. The splicing intermediates and products, tRNA, and U6 snRNA are indicated. Ori designates the gel origin. (G) PIC conditions
with or without PVA were compared with standard RNAP II transcription/splicing conditions. Total bound (lane 1, 3 and 5) and supernatant
(lane 2, 4, 6) fractions were analyzed on a 6.5% denaturing polyacrylamide gel.
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As expected, no transcript was detected with the -b DNA
template, because it did not bind to the streptavidin beads
(Figure 1F, lanes 5 and 6). In previous immobilized
template assay systems, formation of a pre-initiation
complex (PIC) and/or inclusion of polyvinyl alcohol
(PVA) in nuclear extract stimulated transcription or
polyadenylation (25,34,35). Thus, we next compared
these conditions in our transcription/splicing system
using 30b immobilized CMV-Ftz. As shown in
Figure 1G, PIC formation enhanced the levels of Ftz
unspliced and spliced transcript (lanes 3 and 4) relative
to our standard conditions (lanes 5 and 6), and PVA
provided a further increase (lanes 1 and 2). Thus, PIC
conditions with PVA were used to establish the
co-transcriptional splicing system.
In prior studies [(19,22–26,35,36) and references
therein], nascent transcripts were shown to remain quan-
titatively attached to RNAP II if the transcription reaction
was stopped prior to RNAP II ‘running off’ the end of the
DNA template. By deﬁnition, for ‘co-transcriptional
splicing’, the splicing reaction cannot take place while
the transcript is being synthesized because both exon 1,
the intron, and exon 2 must be present in the transcript in
order to undergo splicing. Thus, we next carried out a
transcription time course using immobilized 50bo r3 0b
CMV-Ftz DNA template (Figure 2A and C) to identify
conditions in which the nascent transcript was mostly full
length (and therefore a functional splicing substrate), but
still attached to RNAP II. As shown in Figure 2B and D
(lanes 1–6; see right panels for longer exposure), when the
total RNA in the bound versus supernatant fractions was
compared at the 30, 60 and 90s time points, transcript
ladders of increasing length were detected over time and
were detected only in the bound fraction, indicating that
transcribing RNAP II was associated with the
immobilized DNA template [(25) and references therein].





Figure 2. Transcription time course to analyze association of nascent transcripts with RNAP II bound to the DNA template. (A and C) Schematics
showing transcription of 30b (A) or 50b (C) CMV-Ftz DNA template. (B and D) Immobilized 30b (B) or 50b (D) CMV-Ftz DNA template was
incubated under PIC conditions with PVA for 3000,6 0 00,9 0 00,2 0,3 0,4 0,5 0and 100. Total bound and supernatant fractions were separated, and the
bound fractions were washed in 100mM KCl, 0.1% triton. Bound (lanes 1, 3, 5, 7, 9 11, 13 and 15) and supernatant (lanes 2, 4, 6, 8, 10 12, 14 and
16) fractions were analyzed on a 6.5% denaturing polyacrylamide gel. (B, D) right. Longer exposure of lanes 1–6 for (B) and (D).
Nucleic Acids Research, 2010,Vol.38, No. 21 7573accumulated (Figure 2B and D, lanes 7–16). At the
2–10min time points, transcripts were mostly detected in
the bound fraction, but some run-off transcript was also
detected in the supernatant at the later time points
(Figure 2B and D, lanes 3–16). Thus, consistent with
previous work, our data indicate that the nascent tran-
script remains associated with active RNAP II on the
DNA template at early time points. We chose early
(3–5min) time points for studies of co-transcriptional
splicing because we reproducibly found that most of the
full-length transcript remained bound at this time point.
Co-transcriptional splicing in vitro
We next asked whether splicing could occur while the
nascent transcript was associated with RNAP II on the
immobilized DNA template. Accordingly, we assembled
PICs on the immobilized 30b CMV-Ftz DNA template,
followed by transcription for 5min, addition of
actinomycin D (to stop further transcription), and then
continued incubation for a total of 20 and 50min to
allow splicing. After washing the beads, total RNA in
the bound and supernatant fractions was analyzed
(Figure 3, lanes 1–6). As expected, at the 5-min time
point, only unspliced transcript was detected, and it was
present primarily in the bound fraction (Figure 3, lanes 1
and 2). In contrast, the tRNA present in the nuclear
extract was detected only in the supernatant (Figure 3,
lanes 1 and 2). Signiﬁcantly, when incubation was
continued, the splicing intermediates (lariat-exon 2 and
exon 1) and spliced transcript were detected (Figure 3,
lanes 3–6), and these RNA species were primarily
present in the bound fraction (Figure 3, lanes 3–6).
These data indicate that the nascent transcript can
undergo splicing while associated with RNAP II on the
DNA template. Thus, this system can be used as a simple
in vitro model for co-transcriptional splicing. We also
carried out the co-transcriptional splicing assay without
adding actinomycin D. In this case, splicing began with
the same kinetics as in the presence of actinomycin D
(data not shown). However, at later times of incubation,
transcription continues to occur, but splicing does not,
possibly because splicing factors become limiting in the
nuclear extract more quickly than transcription factors.
In addition, more of the transcripts ‘run-off’ the end of
the DNA template, as expected from the data shown in
Figure 2. Thus, in the studies presented below, we used
actinomycin D in our co-transcriptional splicing system.
In a previous study, spliced transcripts were detected in
association with an immobilized DNA template, but only
when PCR was used for the assay (14). The difference
between their study and ours could be that most of their
transcript had run-off the DNA template.
Evidence that the 50 and 30 portions of the nascent
transcript are associated with RNAP II after RNase H
cleavage within the intron
In recent studies in vivo, Dye and co-workers (13)
generated a transcript that could be co-transcriptionally
cleaved within the intron by a hammerhead ribozyme.
Analysis of splicing using this system revealed that the
transcript was spliced with similar efﬁciency to that of
an intact intron, providing evidence for a molecular
tether between RNAP II and adjacent exons in the tran-
script (13). To investigate whether this type of molecular
tether could be detected using our in vitro system, we
employed oligonucleotide-directed RNase H digestion to
cleave the nascent transcript within the intron. Initially,
we attempted to use CMV-Ftz but encountered technical
difﬁculties due to the small size of the intron. To circum-
vent this problem, we used a construct derived from the
ATM gene, which contains a 339nt intron (Figure 4A, see
schematic) (27,37). As shown in Figure 4A, the
CMV-ATM construct was transcribed by 3min, and by
30min splicing intermediates and products were detected
(spliced transcript is 428nt) (lanes 1 and 2). The intron-
containing species were identiﬁed using oligonucleotide-
directed RNase H cleavage with an oligonucleotide
complementary to the intron (data not shown). When
the CMV-ATM construct was immobilized on beads,
Figure 3. Evidence that nascent transcripts are spliced while tethered to
RNAP II. Immobilized 30b CMV-Ftz DNA template was incubated
under PIC conditions with PVA for 5min, actinomycin D was added,
and incubation was continued for a total of 20 and 50min. The bound
and supernatant fractions were separated, and the bound fractions were
washed in 100mM KCl, 0.1% triton. Total RNA was isolated from the
bound and supernatant fractions and run on a 6.5% denaturing poly-
acrylamide gel.
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spliced transcript were largely detected in the bound
fraction, indicating that, like Ftz, ATM transcripts are
spliced while attached to RNAP II on the immobilized
DNA template (Figure 4B, lanes 1–4). The lariat intron
was largely detected in the supernatant, indicating that
it is not tethered to the RNAP II/spliceosome complex
(the lariat was identiﬁed by cleavage with RNase H,
data not shown).
To determine whether the ATM transcript could be
cleaved within the intron by RNase H, we used an oligo-
nucleotide that should generate a 50 fragment of  228nt
and a 30 fragment of  539nt (Figure 5A). As shown in
Figure 5B, the ATM transcript (lane 1) was cleaved to
completion to generate the expected 50 and 30 fragments
after 5 (lane 2) or 10 (lane 3)min of incubation with the
oligonucleotide. We next investigated the possibility that
the cleaved 50 or 30 fragments remained associated with
RNAP II bound on the DNA template. To do this, the
CMV-ATM DNA template was immobilized on beads,
transcription was carried out for 5min, followed by
addition of the oligonucleotide for 5min. After washing
the beads, RNA in the total bound and supernatant frac-
tions was analyzed. Signiﬁcantly, this analysis revealed
that not only the 30 fragment but also the 50 fragment
were largely present in the bound fraction (Figure 5C,
lanes 1–4), indicating association of these fragments with
RNAP II on the DNA template.
In our system, only picogram levels of transcript are
synthesized from 200ng of the DNA template. Thus,
further studies are needed to optimize the efﬁciency of
the system for biochemical analyses of the factors that
function in co-transcriptional splicing and in tethering
the 50 portion of the transcript to RNAP II.
Evidence that the 50 and 30 portions of nascent transcripts
undergo splicing when associated with RNAP II
In light of the observation that both the 50 and 30 RNase H
cleavage fragments are present in the bound fraction, we
next asked whether spliced transcript could be generated
from these tethered fragments. To do this, the
immobilized CMV-ATM DNA template was incubated
in the RNAP II transcription/splicing system, cleaved
with RNase H, and incubation was continued. The
bound and supernatant fractions were then analyzed. As
shown in Figure 5C, after PIC formation and 5min of
transcription, the nascent transcript was detected in the
bound fraction (lanes 9 and 10). After cleavage with
RNase H for 5min, the 50 and 30 fragments were also
largely present in the bound fraction (Figure 5C, lanes
11 and 12). Signiﬁcantly, when incubation was continued
for a total of 30 or 45min, a band that co-migrated with
the spliced transcript generated from intact unspliced tran-
script (Figure 5C, lanes 5 and 7) was generated from the
RNase H cleavage fragments (lanes 13 and 15). RT–PCR
of these samples revealed a band of the expected size for
the spliced transcript (data not shown), consistent with
conclusion that the cleaved 50 and 30 fragments underwent
splicing. Moreover, as observed with the spliced prod-
uct generated from the intact transcript (Figure 5C,
AB
Figure 4. Splicing of free and immobilized CMV-ATM DNA template. (A) Free CMV-ATM DNA template was incubated under RNAP II
transcription/splicing conditions for the times indicated and analyzed on a 6% denaturing polyacrylamide gel. The unspliced transcript, splicing
intermediates and products are indicated. (B)3 0b CMV-ATM DNA template was immobilized on streptavidin magnetic beads and then incubated
under PIC conditions with PVA. Total bound (lanes 1 and 3) and supernatant (lanes 2 and 4) fractions were analyzed on a 6% denaturing
polyacrylamide gel.
Nucleic Acids Research, 2010,Vol.38, No. 21 7575lanes 5–8), the spliced product generated from the RNase
H-cleaved fragments was present only in the bound
fraction (Figure 5C, lanes 13–16). Together, these data
indicate that the tethered 50 and 30 portions of the tran-
script underwent splicing and that the spliced transcript
remained tethered even after splicing. Although the efﬁ-
ciency of splicing of the RNase H-cleaved transcript was
signiﬁcantly less than that observed with the intact tran-
script (Figure 5C, lanes 5 and 7), this is due, at least in
part, to degradation of the 50 and 30 fragments (Figure 5C,
lanes 13 and 15). Together, our data indicate that the 50
and 30 fragments of the cleaved transcript are tethered to
RNAP II on the DNA template and undergo splicing
while tethered.
DISCUSSION
In this study, we provided evidence that nascent tran-
scripts are efﬁciently spliced in vitro while tethered to




Figure 5. The 50 and 30 portions of the transcript cleaved within the intron by RNase H are tethered to RNAP II and undergo splicing.
(A) Schematic showing 50 and 30 portions of the ATM transcript cleaved within the intron. The short line indicates the oligonucleotide used for
RNase H cleavage, and the sizes of the 50 and 30 cleavage products are indicated. (B)3 0b CMV-ATM DNA template was incubated under RNAP II
transcription/splicing conditions for 10min (lanes 1). The oligonucleotide was then added and incubation was continued for 5 (lane 2) or 10min
(lane 3). The RNA was cleaved by the endogenous RNase H in the nuclear extract, and the 50 and 30 cleavage fragments are indicated. (C)3 0b
CMV-ATM DNA template was immobilized on streptavidin magnetic beads and then incubated under PIC conditions with PVA for 5min (lanes 1
and 2) followed by addition of actinomycin D and oligonucleotide for 5min (lanes 3 and 4), or only actinomycin D for 25min (lanes 5 and 6) and
40min (lanes 7 and 8). Lanes 9–12 are the same as lanes 1–4. An aliquot of the sample shown in lane 11 was incubated further, for a total of 30 and
45min, and then RNA from total bound and supernatant fractions was analyzed on a 5.75% denaturing polyacrylamide gel (lanes 13–16).
7576 Nucleic Acids Research, 2010,Vol.38, No. 21occurs prior to release of the transcript from RNAP II,
this study provides the ﬁrst simple efﬁcient model in vitro
system for co-transcriptional splicing. Recently, an elegant
study in vivo showed that transcription occurs at the rate
of 3800nt per minute and that co-transcriptional splicing
occurs within 5–10min of synthesis (11). In our in vitro
system, both transcription and co-transcriptional splicing
are about 5–10 times slower, possibly due to dilution of
the extracts, limiting factors, or packaging of the DNA.
Nevertheless, the observation that our rates are not that
far off from those observed in vivo indicates that the
in vitro system is a useful model for co-transcriptional
splicing studies.
Most transcripts in higher eukaryotes contain numerous
exons ﬂanked by large introns. The exon-tethering model,
in which the upstream exon is tethered to RNAP II until
the downstream exon is synthesized, has been proposed to
explain how exons are correctly joined to each other in
sequential order. Previous work in vivo showed that that
nascent transcripts are efﬁciently spliced when the intron
is cleaved in the middle with a hammerhead ribozyme (13).
Thus, these data suggested the existence of a molecular
tether between the exons and RNAP II, supporting the
exon-tethering model (13). This model has gained add-
itional support by the observation that splicing in vivo
occurs at similar rates whether the intron is 1kb or
>200kb (11). This similarity in rates could occur if the
upstream exon is tethered to RNAP II until the down-
stream exon is synthesized (11). Studies using our
in vitro co-transcriptional splicing system also support
the exon-tethering model and provide new insights.
When we cleaved the tethered transcript within the
intron using an oligonucleotide and RNase H, both the
50 and 30 fragments of the transcript were present in
the bound fraction, indicating that they are associated
with the RNAP II on the DNA template. Previous work
indicates that the 30 portion of the transcript is directly
attached to the elongating RNAP II [(25) and references
therein]. It is not known how the 50 portion of the tran-
script is associated with RNAP II, i.e. whether the
50 portion is directly tethered to RNAP II or associates
with it indirectly via other factors, such as spliceosome
components. Recently, Bentley and co-workers found
that splicing in vivo did not occur if an intron
was cleaved by a fast ribozyme (hepatitis d) whereas
splicing did occur if a slower cleaving hammerhead
ribozyme was used (38). These data raise the possibility
that spliceosome components are able to associate
with the transcript when the slower ribozyme is used,
and these spliceosome components may play a role
in tethering the 50 exon to RNAP II (38). Our studies
in which we do detect splicing after cleaving the intron
with RNase H appear to be more similar
to the slower cleaving ribozyme work in vivo (13,38)
and indicate that spliceosome components mediate the
interaction between the RNase H-cleaved transcript and
RNAP II. In a previous study, in which transcription
and polyadenylation occurred on an immobilized
template, Price and co-workers found that the 50 portion
of an RNase H-cleaved transcript was associated with the
DNA template in a functional polyadenylation-competent
complex (35). As this transcript lacked splice sites,
polyadenylation factors likely mediate tethering of the
50 fragment to RNAP II (35).
Our data show that the spliced transcript containing
exons 1 and 2 remains tethered to RNAP II. Thus, it is
possible that in multi-exon transcripts, all of the upstream
spliced exons, or the upstream pair of spliced exons,
remain tethered until the next exon is synthesized,
thereby ensuring correct joining to the emerging down-
stream exon. Considering that the vast majority of
RNAP II transcripts undergo alternative splicing,
speciﬁc mechanisms must exist to ensure that correct
ordering of exons occurs in the context of this greater
level of complexity. In the simplest view, alternative
exons would be looped out similar to intron sequences
and thereby not associate with RNAP II. The in vitro
co-transcriptional splicing system described here
provides a new model for elucidating the mechanisms
involved in co-transcriptional splicing.
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